Ваш браузер устарел. Рекомендуем обновить его до последней версии.

We are high professional team with great experience in R&D and innovative business development:



Zemskova Marina - Chief Sciense Officer. Ph.D. Biology.

Areas of interest: Translational research; Signal transduction; Molecular and cellular proteomics; Molecular biology/genomics based drug discovery; Small molecule therapeutics; Tumor microenvironment; Biomarkers discovery.

Member of American Association for Cancer Research (AACR);

Member of Tumor Microenvironment Working Group.


Keshelava Varlam - Development Adviser. Ph.D. Biology.

Intellectual property specialist.

Former managing director  and main expert of 'Sygma' (venture company). 

15 innovative projects were successfully launched under his management.

Total investment over $200MM.


Sorokin Konstantin - CEO. 

Education: Physical Department, Moscow State University.

Master of Business Administration.

Over 5 years experience in managing innovative projects.

Bortnik's Fund expert (R&D and business development).

Central Russian Economic Forum's expert (innovations, start-ups).